These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 38789258)

  • 1. What do clinical practice guidelines say about deprescribing? A scoping review.
    Langford AV; Warriach I; McEvoy AM; Karaim E; Chand S; Turner JP; Thompson W; Farrell BJ; Pollock D; Moriarty F; Gnjidic D; Ailabouni NJ; Reeve E
    BMJ Qual Saf; 2024 May; ():. PubMed ID: 38789258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing.
    Farrell B; Pottie K; Rojas-Fernandez CH; Bjerre LM; Thompson W; Welch V
    PLoS One; 2016; 11(8):e0161248. PubMed ID: 27517450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines.
    Hamilton M; Kwok WS; Hsu A; Mathieson S; Gnjidic D; Deyo R; Ballantyne J; Von Korff M; Blyth F; Lin CC
    Pain; 2023 Mar; 164(3):485-493. PubMed ID: 36001299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing recommendations: An essential consideration for clinical guideline developers.
    Moriarty F; Pottie K; Dolovich L; McCarthy L; Rojas-Fernandez C; Farrell B
    Res Social Adm Pharm; 2019 Jun; 15(6):806-810. PubMed ID: 30241877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe.
    Shrestha S; Giri R; Sapkota HP; Danai SS; Saleem A; Devkota S; Shrestha S; Adhikari B; Poudel A
    Ther Adv Drug Saf; 2021; 12():20420986211019309. PubMed ID: 34211689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review.
    Wang Y; Wilson DL; Fernandes D; Adkins LE; Bantad A; Copacia C; Dharma N; Huang PL; Joseph A; Park TW; Budd J; Meenrajan S; Orlando FA; Pennington J; Schmidt S; Shorr R; Uphold CR; Lo-Ciganic WH
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools for deprescribing in severe dementia: A scoping review.
    Wang C; Roberts E; Smith G; Carland JE; Cordato NJ
    Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5959. PubMed ID: 37395164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review.
    Brandt J; Bressi J; Lê ML; Neal D; Cadogan C; Witt-Doerring J; Witt-Doerring M; Wright S
    EClinicalMedicine; 2024 Apr; 70():102507. PubMed ID: 38516102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis.
    Shrestha S; Poudel A; Cardona M; Steadman KJ; Nissen LM
    Ther Adv Drug Saf; 2021; 12():20420986211052343. PubMed ID: 34707802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations on deprescribing of bisphosphonates in osteoporosis guidelines: a systematic review.
    Jepsen DB; Bergen ES; Pan J; van Poelgeest E; Osman A; Burghle A; Ryg J; Thompson W; Lundby C
    Eur Geriatr Med; 2023 Aug; 14(4):747-760. PubMed ID: 37393587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations.
    Langford AV; Lin CC; Bero L; Blyth FM; Doctor J; Holliday S; Jeon YH; Moullin J; Murnion B; Nielsen S; Osman R; Penm J; Reeve E; Reid S; Wale J; Schneider CR; Gnjidic D
    Med J Aust; 2023 Jul; 219(2):80-89. PubMed ID: 37356051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.
    Langford AV; Gnjidic D; Lin CC; Bero L; Penm J; Blyth FM; Schneider CR
    BMJ Qual Saf; 2021 Feb; 30(2):133-140. PubMed ID: 32220937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
    Farrell B; Richardson L; Raman-Wilms L; de Launay D; Alsabbagh MW; Conklin J
    Res Social Adm Pharm; 2018 Jan; 14(1):18-25. PubMed ID: 28214150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electronic Decision Support for Deprescribing in Patients on Hemodialysis: Clinical Research Protocol for a Prospective, Controlled, Quality Improvement Study.
    Bortolussi-Courval É; Podymow T; Trinh E; Moryousef J; Hanula R; Huon JF; Mavrakanas T; Suri R; Lee TC; McDonald EG
    Can J Kidney Health Dis; 2023; 10():20543581231165712. PubMed ID: 37435299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.